Skip to main
OPNV
Privately held company

OpenEvidence

$545.42

Source: Nasdaq Private Markets
$40.62 (8.05%)past six months
Thursday, September 24$35.61 (7.05%)

OpenEvidence raised $230M in Series D-3 round on Sep 24, 2026.

OpenEvidence Valuation

Follow estimated valuations, share price trends, and company updates for OpenEvidence.

Get updates

About OpenEvidence

OpenEvidence delivers an AI-driven platform that helps healthcare professionals effortlessly explore and understand medical research. It synthesizes peer-reviewed clinical studies and multimedia into digestible insights that support informed decision making at the point of care. The platform seamlessly integrates evidence-based content into clinicians’ workflows to enhance patient outcomes.
Co-FounderZachary Ziegler
CEODaniel Nadler
CTOZachary Ziegler
HeadquartersCambridge, MA
Founded2019
SectorHealthcare & Life Sciences

OpenEvidence Funding History

Financing RoundDateAmount
Series D-3Sep 24, 2026$230M
Series DJan 21, 2026$225M
Series C-2Oct 20, 2025$125M
Series C-2Oct 20, 2025$75M
Series B-1Jul 15, 2025$30M
Series B-1Jul 15, 2025$125M

OpenEvidence lead investors

  • Andreessen Horowitz
  • Blackstone
  • BOND
  • Coatue
  • Craft Ventures
  • DST Global
  • Google Ventures
  • Greycroft
  • Kleiner Perkins Caufield & Byers
  • Sequoia
  • Thrive Capital

FAQ

Frequently asked questions

OpenEvidence's estimated secondary market share price is $545.42 as of October 2026.

OpenEvidence's last official round, Series D-3, was for $230M.

OpenEvidence's last known funding was on Sep 24, 2026 for $230M.

OpenEvidence's major investors are Andreessen Horowitz, Blackstone, BOND, Coatue, Craft Ventures, DST Global, Google Ventures, Greycroft, Kleiner Perkins Caufield & Byers, Sequoia, Thrive Capital.

As of November 11, 2026, OpenEvidence is not yet publicly traded.

Private companies

OpenEvidence Valuation

Follow estimated valuations, share price trends, and company updates for OpenEvidence.

Get updates

Private companies

Follow OpenEvidence valuations and private market trends